Skip to main content
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 6
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Jackson, Anne Silk, Sarah Buhidma, Yazead and Shoaib, Mohammed 2016. Varenicline, the clinically effective smoking cessation agent, restores probabilistic response reversal performance during withdrawal from nicotine. Addiction Biology,

    Ramilowski, Jordan A. Goldberg, Tatyana Harshbarger, Jayson Kloppman, Edda Lizio, Marina Satagopam, Venkata P. Itoh, Masayoshi Kawaji, Hideya Carninci, Piero Rost, Burkhard and Forrest, Alistair R. R. 2015. A draft network of ligand–receptor-mediated multicellular signalling in human. Nature Communications, Vol. 6, p. 7866.

    Persson, N. Lavebratt, C. and Wahlin, Å. 2013. Synergy effects of HbA1c and variants of APOE and BDNFVal66Met explains individual differences in memory performance. Neurobiology of Learning and Memory, Vol. 106, p. 274.

    Reinvang, Ivar Espeseth, Thomas and Westlye, Lars Tjelta 2013. APOE-related biomarker profiles in non-pathological aging and early phases of Alzheimer's disease. Neuroscience & Biobehavioral Reviews, Vol. 37, Issue. 8, p. 1322.

    Tuminello, Elizabeth R. and Han, S. Duke 2011. The Apolipoprotein E Antagonistic Pleiotropy Hypothesis: Review and Recommendations. International Journal of Alzheimer's Disease, Vol. 2011, p. 1.

    2010. Current awareness in geriatric psychiatry. International Journal of Geriatric Psychiatry, Vol. 25, Issue. 12, p. i.

  • Journal of the International Neuropsychological Society, Volume 16, Issue 3
  • May 2010, pp. 424-432

Epistasis between APOE and nicotinic receptor gene CHRNA4 in age related cognitive function and decline

  • DOI:
  • Published online: 01 March 2010

Healthy participants (n = 237) aged 45–79 were tested neuropsychologically with tests of memory, speed, and cognitive control and followed up for 3–5 years (mean, 3.4 years). The sample was genotyped for apolipoprotein E (APOE) and CHolinergic Receptor for Nicotine Alpha 4 (CHRNA4), and genetic effects on cognitive function at initial testing and on cognitive decline was studied. We predicted relatively stronger effects of APOE on memory, and of CHRNA4 on speeded tasks. The predictions were partially confirmed, but we found interactive effects of APOE and CHRNA4 in several cognitive domains. Being an APOE ε4/CHRNA4 TT carrier was associated with slower and less efficient performance, and with steeper decline in speed tasks and in delayed recall. Age dependent genetic effects were found for both APOE and CHRNA4, where old participants (60–79 years) showed a negative influence of TT carrier status on initial memory performance, but a tendency for steeper memory decline in ε4 carriers. Inconsistent and small effects of APOE reported in previous studies of healthy groups may be caused by failure to consider epistasis of APOE with nicotinic receptor and other genes. (JINS, 2010, 16, 424–432.)

Corresponding author
*Correspondence and reprint requests to: Ivar Reinvang, Department of Psychology, Center for the Study of Human Cognition, University of Oslo, Box 1094 Blindern, N-0317 Oslo, Norway. E-mail:
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

S.J. Allen , S.H. MacGowan , S. Tyler , G.K. Wilcock , A.G. Robertson , P.H. Holden , (1997). Reduced cholinergic function in normal and Alzheimer’s disease brain is associated with apolipoprotein E4 genotype. Neuroscience Letters, 239, 3336.

L.C. Baxter , R.J. Caselli , S.C. Johnson , E. Reiman , & D. Osborne (2003). Apolipoprotein E epsilon 4 affects new learning in cognitively normal individuals at risk for Alzheimer’s disease. Neurobiology of Aging, 24, 947952.

L. Bertram (2009). Alzheimer’s disease genetics current status and future perspectives. International Review of Neurobiology, 84, 167184.

S.Y. Bookheimer , M.H. Strojwas , M.S. Cohen , A.M. Saunders , M.A. Pericak-Vance , J.C. Mazziotta , (2000). Patterns of brain activation in people at risk for Alzheimer’s disease. New England Journal of Medicine, 343, 450456.

P. Bretsky , J.M. Guralnik , L. Launer , M. Albert , & T.E. Seeman (2003). The role of APOE-epsilon4 in longitudinal cognitive decline: MacArthur studies of successful aging. Neurology, 60, 10771081.

L. Burghaus , U. Schütz , U. Krempel , R.A. de Vos , E.N. Jansen Steur , A. Wevers , (2000). Quantitative assessment of nicotinic acetylcholine receptor proteins in the cerebral cortex of Alzheimer patients. Brain Research: Molecular Brain Research, 76, 385388.

R.J. Caselli , E.M. Reiman , D.E. Locke , M.L. Hutton , J.G. Hentz , C. Hoffman-Snyder , (2007). Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment. Archives of Neurology, 64, 13061311.

R.J. Caselli , E.M. Reiman , D. Osborne , J.G. Hentz , L.C. Baxter , J.L. Hernandez , (2004). Longitudinal changes in cognition and behavior in asymptomatic carriers of the APOE e4 allele. Neurology, 62, 19901995.

K. Chen , E.M. Reiman , G.E. Alexander , R.J. Caselli , R. Gerkin , D. Bandy , (2007). Correlations between apolipoprotein E epsilon4 gene dose and whole brain atrophy rates. American Journal of Psychiatry, 164, 916921.

N. Cherbuin , L.S. Leach , H. Christensen , & K.J. Anstey (2007). Neuroimaging and APOE genotype: A systematic qualitative review. Dementia & Geriatric Cognitive Disorders, 24, 348362.

H. Christensen , P.J. Batterham , A.J. Mackinnon , A.F. Jorm , H.A. Mack , K.A. Mather , (2008). The association of APOE genotype and cognitive decline in interaction with risk factors in a 65–69 year old community sample. BMC Geriatrics, 8, 14.

L.J. Cook , L.W. Ho , A.E. Taylor , C. Brayne , J.G. Evans , J. Xuereb , (2004). Candidate gene association studies of the α4 (CHRNA4) and β2 (CHRNB2) neuronal nicotinic acetylcholine receptor subunit genes in Alzheimer’s disease. Neuroscience Letters, 358, 142146.

E.H. Corder , A.M. Saunders , W.J. Strittmatter , D.E. Schmechel , P.C. Gaskell , G.W. Small , (1993). Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science, 261, 921923.

J.A. Court , C. Martin-Ruiz , A. Graham , & E. Perry (2000). Nicotinic receptors in human brain: Topography and pathology. Journal of Chemical Neuroanatomy, 20, 281298.

J.A. Dani , & D. Bertrand (2007). Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annual Review of Pharmacology and Toxicology, 47, 699729.

T. Espeseth , T. Endestad , H. Rootwelt , & I. Reinvang (2007). Nicotine receptor gene CHRNA4 modulates early event-related potentials in auditory and visual oddball target detection tasks. Neuroscience, 147, 974985.

T. Espeseth , P.M. Greenwood , I. Reinvang , A.M. Fjell , K.B. Walhovd , L.T. Westlye , (2006). Interactive effects of APOE and CHRNA4 on attention and white matter volume in healthy middle-aged and older adults. Cognitive & Affective Behavioral Neuroscience, 6, 3143.

J.D. Flory , S.B. Manuck , R.E. Ferrell , C.M. Ryan , & M.F. Muldoon (2000). Memory performance and the apolipoprotein E polymorphism in a community sample of middle-aged adults. American Journal of Medical Genetics, 96, 707711.

M.F. Folstein , S.E. Folstein , & P.R. McHugh (1975). Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189198.

P.M. Greenwood , J.A. Fossella , & R. Parasuraman (2005). Specificity of the effect of a nicotinic receptor polymorphism on individual differences in visuospatial attention. Journal of Cognitive Neuroscience, 17, 16111620.

P.M. Greenwood , M.K. Lin , R. Sundararajan , K.J. Fryxell , & R. Parasuraman (2009). Synergistic effects of genetic variation in nicotinic and muscarinic receptors on visual attention but not working memory. Proceedings of the National Academy of Sciences of the United States of America, 106, 36333638.

C.R. Jack Jr., V.J. Lowe , S.D. Weigand , H.J. Wiste , M.L. Senjem , D.S. Knopman , (2009). Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer’s disease: Implications for sequence of pathological events in Alzheimer’s disease. Brain. 132, 13551365.

A.F. Jorm , K.A. Mather , P. Butterworth , K.J. Anstey , H. Christensen , & S. Easteal (2007). APOE genotype and cognitive functioning in a large age stratified population sample. Neuropsychology, 21, 18.

M.K. Lai , S.W. Tsang , M. Garcia-Alloza , S.L. Minger , J.A. Nicoll , M.M. Esiri , (2006). Selective effects of the APOE epsilon4 allele on presynaptic cholinergic markers in the neocortex of Alzheimer’s disease. Neurobiology of Disease, 22, 555561.

S. Le Hellard , B. Håvik , T. Espeseth , H. Breilid , R. Løvlie , M. Luciano , (2009). Variants in doublecortin- and calmodulin kinase like 1, a gene up-regulated by BDNF, are associated with memory and general cognitive abilities. PLoS One, 4, e7534.

J. Lind , A. Larsson , J. Persson , M. Ingvar , L.G. Nilsson , L. Bäckman , (2006). Reduced hippocampal volume in non-demented carriers of the apolipoprotein E epsilon4: Relation to chronological age and recognition memory. Neuroscience Letters, 396, 2327.

J. Lind , J. Persson , M. Ingvar , A. Larsson , M. Cruts , C. Van Broeckhoven , (2006). Reduced functional brain activity response in cognitively intact apolipoprotein ε4 carriers. Brain, 129, 12401248.

M. Luciano , A.J. Gow , M.D. Taylor , C. Hayward , S.E. Harris , H. Campbell , (2009). Apolipoprotein E is not related to memory abilities at 70 Years of age. Behavior Genetics, 39, 614.

R.W. Mahley , K.H. Weisgraber , & Y. Huang (2006). Apolipoprotein E4: A causative factor and therapeutic target in neuropathology, including Alzheimer’s disease. Proceedings of the National Academy of Sciences of the United States of America, 103, 56445651.

C.M. Martin-Ruiz , J.A. Court , E. Molnar , M. Lee , C. Gotti , A. Mamalaki , (1999). Alpha4 but not alpha3 and alpha7 nicotinic acetylcholine receptor subunits are lost from the temporal cortex in Alzheimer’s disease. Journal of Neurochemistry, 73, 16351640.

R. Mayeux , S.A. Small , M. Tang , B. Tycko , & Y. Stern (2001). Memory performance in healthy elderly without Alzheimer’s disease: Effects of time and apolipoprotein-E. Neurobiology of Aging, 22, 683689.

E.M. Mitsis , K.P. Cosgrove , J.K. Staley , F. Bois , E.B. Frohlich , G.D. Tamagnan , (2009). Age-related decline in nicotinic receptor availability with [123I]5-IA-85380 SPECT, Neurobiology of Aging, 30, 14901497.

L.G. Nilsson , R. Adolfsson , L. Backman , M. Cruts , L. Nyberg , B.J. Small , (2006). The influence of APOE status on episodic and semantic memory: Data from a population-based study. Neuropsychology, 20, 645657.

A. Nordberg (2004). Functional studies of cholinergic activity in normal and Alzheimer disease states by imaging technique. Progress in Brain Research, 145, 301309.

S. Oddo , & F.M. LaFerla (2006). The role of nicotinic acetylcholine receptors in Alzheimer’s disease. Journal of Physiology Paris, 99, 172179.

A. Papassotiropoulos , D.A. Stephan , M.J. Huentelman , F.J. Hoerndli , D.W. Craig , J.V. Pearson , (2006). Common Kibra alleles are associated with human memory performance. Science, 314, 475478.

R. Parasuraman , P.M. Greenwood , R. Kumar , & J. Fossella (2005). Beyond heritability: Neurotransmitter genes differentially modulate visuospatial attention and working memory. Psychological Science, 16, 200207.

P.C. Phillips (2008). Epistasis - the essential role of gene interactions in the structure and evolution of genetic systems. Nature Reviews Genetics, 9, 855867.

S.L. Pimlott , M. Piggott , J. Owens , E. Greally , J.A. Court , E. Jaros , (2004). Nicotinic acetylcholine receptor distribution in Alzheimer’s disease, dementia with Lewy bodies, Parkinson’s disease, and vascular dementia: In vitro binding study using 5-[(125)i]-a-85380. Neuropsychopharmacology, 29, 108116.

J. Poirier , M.C. Delisle , R. Quirion , I. Aubert , M. Farlow , D. Lahiri , (1995). Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America, 92, 1226012264.

J. Raber , Y. Huang , & J.W. Ashford (2004). ApoE genotype accounts for the vast majority of AD risk and AD pathology. Neurobiology of Aging, 25, 641650.

E.M. Reiman , R.J. Caselli , L.S. Yun , K. Chen , D. Bandy , S. Minoshima , (1996). Preclinical evidence of Alzheimer’s disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. New England Journal of Medicine, 334, 752758.

E.M. Reiman , K. Chen , X. Liu , D. Bandy , M. Yu , W. Lee , (2009). Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer’s disease. Proceedings of the National Academy of Sciences of the United States of America, 106, 68206825.

I. Reinvang , A.J. Lundervold , H. Rootwelt , E. Wehling , & T. Espeseth (2009). Individual variation in a cholinergic receptor gene modulates attention. Neuroscience Letters, 453, 131134.

C.A. Reynolds , J.A. Prince , L. Feuk , A.J. Brookes , M. Gatz , & N.L. Pedersen (2006). Longitudinal memory performance during normal aging: Twin association models of APOE and other Alzheimer candidate genes. Behavior Genetics, 36, 185194.

A. Salehi , E.J. Dubelaar , M. Mulder , & D.F. Swaab (1998). Aggravated decrease in the activity of nucleus basalis neurons in Alzheimer’s disease is apolipoprotein E-type dependent. Proceedings of the National Academy of Sciences of the United States of America, 95, 1144511449.

M. Sarter , & J.P. Bruno (2004). Developmental origins of the age related decline in cortical cholinergic function and associated cognitive abilities. Neurobiology of Aging, 25, 11271139.

B.M. Schjeide , M.B. McQueen , K. Mullin , J. DiVito , M.F. Hogan , M. Parkinson , (2009). Assessment of Alzheimer’s disease case-control associations using family-based methods. Neurogenetics, 10, 1925.

M.R. Schultz , M.J. Lyons , C.E. Franz , M.D. Grant , C. Boake , K.C. Jacobson , (2008). Apolipoprotein E genotype and memory in the sixth decade of life. Neurology, 70, 17711777.

B.J. Small , C.B. Rosnick , L. Fratiglioni , & L. Backman (2004). Apolipoprotein E and cognitive performance: A meta-analysis. Psychology of Aging, 19, 592600.

G.W. Small , P. Siddarth , A.C. Burggren , V. Kepe , L.M. Ercoli , K.J. Miller , (2009). Influence of cognitive status, age, and APOE-4 genetic risk on brain FDDNP positron-emission tomography imaging in persons without dementia. Archives of General Psychiatry, 66, 8187.

J.R. Stroop (1935). Studies of interference in serial verbal reactions. Journal of Experimental Psychology, 18, 643662.

V. Thorvaldsson , S.M. Hofer , S. Berg , I. Skoog , S. Sacuiu , & B. Johansson (2008). Onset of terminal decline in cognitive abilities in individuals without dementia. Neurology, 71, 882887.

H. Tohgi , K. Utsugisawa , M. Yoshimura , Y. Nagane , & M. Mihara (1998). Age-related changes in nicotinic acetylcholine receptor subunits alpha4 and beta2 messenger RNA expression in postmortem human frontal cortex and hippocampus. Neuroscience Letters, 245, 139142.

J.L. Whitwell , S.A. Przybelski , S.D. Weigand , D.S. Knopman , B.F. Boeve , R.C. Petersen , (2007). 3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer’s disease. Brain, 130, 17771786.

R.S. Wilson , J.A. Schneider , L.L. Barnes , L.A. Beckett , N.T. Aggarwal , E.J. Cochran , (2002). The apolipoprotein E epsilon 4 allele and decline in different cognitive systems during a 6-year period. Archives of Neurology, 59, 11541160.

G. Winterer , F. Musso , A. Konrad , G. Vucurevic , P. Stoeter , T. Sander , (2007). Association of attentional network function with exon 5 variations of the CHRNA4 gene. Human Molecular Genetics, 16, 21652174.

T. Espeseth , L.T. Westlye , A.M. Fjell , K.B. Walhovd , H. Rootwelt , & I. Reinvang (2008). Accelerated age-related cortical thinning in healthy carriers of apolipoprotein E epsilon 4. Neurobiology of Aging, 29, 329340.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Journal of the International Neuropsychological Society
  • ISSN: 1355-6177
  • EISSN: 1469-7661
  • URL: /core/journals/journal-of-the-international-neuropsychological-society
Please enter your name
Please enter a valid email address
Who would you like to send this to? *